Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors
Authors:
Top Cited Papers
- 21 September 2023
- journal article
- research article
- Published by Springer Nature in Science China Life Sciences
- Vol. 67 (1) , 122-131
Abstract
China faces a disproportionate cancer burden to the population size and is undergoing a transition in the cancer spectrum. We extracted data in five aspects of cancer incidence, mortality, survival, staging distributions, and attribution to risk factors in China, the USA and worldwide from open-source databases. We conducted a comprehensive secondary analysis of cancer profiles in China in the above aspects, and compared cancer statistics between China and the USA. A total of 4,546,400 new cancer cases and 2,992,600 deaths occurred in China in 2020, accounting for 25.1% and 30.2% of global cases, respectively. Lifestyle-related cancers including lung cancer, colorectal cancer, and breast cancer showed an upward trend and have been the leading cancer types in China. 41.6% of new cancer cases and 49.3% of cancer deaths occurred in digestive-system cancers in China, and the cancers of esophagus, nasopharynx, liver, and stomach in China accounted for over 40% of global cases. Infection-related cancers showed the highest population-attributable fractions among Chinese adults, and most cancers could be attributed to behavioral and metabolic factors. The proportions of stage I for most cancer types were much higher in the USA than in China, except for esophageal cancer (78.2% vs. 41.1%). The 5-year relative survival rates in China have improved substantially during 2000–2014, whereas survival for most cancer types in the USA was significantly higher than in China, except for upper gastrointestinal cancers. Our findings suggest that although substantial progress has been made in cancer control, especially in digestive system cancers in China, there was still a considerable disparity in cancer burden between China and the USA. More robust policies on risk factors and standardized screening practices are urgently warranted to curb the cancer growth and improve the prognosis for cancer patients.Keywords
This publication has 52 references indexed in Scilit:
- Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-AnalysisGastroenterology, 2017
- Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013JAMA, 2017
- Age, period and cohort effects on adult physical activity levels from 1991 to 2011 in ChinaInternational Journal of Behavioral Nutrition and Physical Activity, 2016
- Inpatient care burden due to cancers in Anhui, China: a cross-sectional household surveyBMC Public Health, 2016
- Prevalence and Secular Trends in Obesity Among Chinese Adults, 1991−2011American Journal of Preventive Medicine, 2015
- Alcohol and related health issues in China: action neededThe Lancet Global Health, 2015
- Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of ChinaCarcinogenesis, 2013
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based studyThe Lancet Oncology, 2012
- Preventable Exposures Associated With Human CancersJNCI: Journal of the National Cancer Institute, 2011
- Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control MeasuresJournal of Epidemiology, 2011